InvestorsHub Logo

uvaphd

01/03/20 8:59 AM

#96645 RE: Doubledown75 #96644

Agreed completely. My only complaint is that I have yet to hear a rationale for the slow (now glacial) progress. They’ve been talking about commercialization of CaverStem for approaching 2 years—and yet we seem to have completed a mere 50ish procedures during the entire quarter reported on 9/30/19. Moreover, we have heard NOTHING on Russia or cachexia, among other items of interest.